No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Kura Oncology Grants 190,000 Stock Options To Six New Employees As Inducement Awards
Press Release: Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
UBS Maintains Kura Oncology(KURA.US) With Buy Rating, Cuts Target Price to $14
Analysts Are Bullish on Top Healthcare Stocks: HCA Healthcare (HCA), Kura Oncology (KURA)
Kura Oncology's Financial Future at Risk: Dependency on Kyowa Kirin for Ziftomenib Development Raises Concerns
JMP Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28